North America Neuromodulation Devices Outlook to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: January 15, 2020 Report Code: GDMECR1237DB-ST

Select Item

“What is covered in the report about the “North America Neuromodulation Devices Market”?
GlobalData’s “North America Neuromodulation Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the North America Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The North America Neuromodulation Devices Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Neuromodulation Devices market.
• Global corporate-level profiles of key companies operating within the North America Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

North America Neuromodulation Devices is segmented as follows:
• Deep Brain Stimulators (DBS)
• Gastric Electric Stimulators (GES)
• Leads
• Peripheral Nerve Stimulators (PNS)
• Sacral Nerve Stimulators (SNS)
• Spinal Cord Stimulators (SCS)
• Vagus Nerve Stimulators (VNS)

Key Reasons to Purchase
The North America Neuromodulation Devices Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “North America Neuromodulation Devices Market Outlook to 2025” report
• Medtronic plc
• Abbott Laboratories

The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 15,000+ primary interviews, conducted annually to ensure data and report quality
• 3,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 66.956+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 825+ companies’ revenue splits and market shares
• 2,000+ quarterly and annual medical equipment company financials
• 1,100+ medical equipment company SWOTs
• 26,400+ pipeline product profiles
• 52,400+ marketed product profiles
• 44,600+ clinical trials
• 52,400+ trial investigators
• 7,900+ reports on companies with products in development
• 42,000+ deals in the medical equipment industry
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx

Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 7

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Neuromodulation Devices Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 Neuromodulation Devices Market, North America 11

3.1 Neuromodulation Devices Market, North America, Revenue ($m), 2015-2025 11

3.2 Neuromodulation Devices Market, North America, Revenue ($m), 2015-2025 13

3.3 Neuromodulation Devices Market, North America, Volume (Units), 2015-2025 16

3.4 Neuromodulation Devices Market, North America, Volume (Units), 2015-2025 18

3.5 Neuromodulation Devices Market, North America, Company Share by Revenue ($m), 2018 21

4 Neuromodulation Devices Market, Canada 23

4.1 Neuromodulation Devices Market, Canada, Revenue ($m), 2015-2025 23

4.2 Neuromodulation Devices Market, Canada, Volume (Units), 2015-2025 26

4.3 Neuromodulation Devices Market, Canada, Average Price ($), 2015-2025 29

4.4 Neuromodulation Devices Market, Canada, Distribution Share by Revenue ($m), 2018 31

4.5 Neuromodulation Devices Market, Canada, Company Share by Revenue ($m), 2018 32

5 Neuromodulation Devices Market, Mexico 34

5.1 Neuromodulation Devices Market, Mexico, Revenue ($m), 2015-2025 34

5.2 Neuromodulation Devices Market, Mexico, Volume (Units), 2015-2025 37

5.3 Neuromodulation Devices Market, Mexico, Average Price ($), 2015-2025 40

5.4 Neuromodulation Devices Market, Mexico, Distribution Share by Revenue ($m), 2018 42

5.5 Neuromodulation Devices Market, Mexico, Company Share by Revenue ($m), 2018 43

6 Neuromodulation Devices Market, United States 45

6.1 Neuromodulation Devices Market, United States, Revenue ($m), 2015-2025 45

6.2 Neuromodulation Devices Market, United States, Volume (Units), 2015-2025 48

6.3 Neuromodulation Devices Market, United States, Average Price ($), 2015-2025 51

6.4 Neuromodulation Devices Market, United States, Distribution Share by Revenue ($m), 2018 53

6.5 Neuromodulation Devices Market, United States, Company Share by Revenue ($m), 2018 54

7 Overview of Key Companies in North America Neuromodulation Devices Market 56

7.1 Medtronic Plc 56

7.1.1 Company Overview 56

7.2 Boston Scientific Corp 56

7.2.1 Company Overview 56

7.3 Abbott Laboratories 56

7.3.1 Company Overview 56

7.4 LivaNova PLC 57

7.4.1 Company Overview 57

7.5 Nevro Corp 57

7.5.1 Company Overview 57

7.6 Nuvectra Corp 57

7.6.1 Company Overview 57

8 Neuromodulation Devices Market Pipeline Products 58

9 Recent Developments 72

9.1 Corporate Communications 72

9.1.1 Nov 19, 2019: Winterlight Labs raises Series A funds to develop AI vocal technology 72

9.1.2 Nov 14, 2019: Zynex ranked 18th in revenue growth among medical device companies 72

9.1.3 Nov 01, 2019: Neuronetics announces appointment of Sheryl Conley to its board of directors 72

9.1.4 Sep 30, 2019: electroCore appoints Medical Technology Veteran Daniel S. Goldberger as Chief Executive Officer 73

9.1.5 Sep 19, 2019: BrainsWay announces further leadership transition to U.S. 73

9.1.6 Sep 10, 2019: SetPoint Medical appoints Anna Gawlicka as VP of Clinical Affairs 74

9.1.7 Aug 28, 2019: Dynatronics promotes Brian Baker to Chief Executive Officer 74

9.1.8 Aug 21, 2019: NuVasive: Departure of directors or certain officers 75

9.1.9 Aug 21, 2019: Avanos Medical: Changes in senior management 75

9.1.10 Aug 12, 2019: GSK announces leadership changes in the US 75

9.1.11 Aug 06, 2019: Healthcare Veteran Kristine Johnson to join MRI Interventions' board of directors 76

9.1.12 Jul 31, 2019: NeuroPace appoints Mark Saxton as vice president of sales 76

9.1.13 Jul 25, 2019: Inspire Medical Systems announces changes to its board of directors 77

9.1.14 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 77

9.1.15 Jul 23, 2019: Zynex recognized as the fastest growing public company in Colorado based on net income 77

9.1.16 Jul 22, 2019: Zynex expands executive team, appoints Joseph Papandrea chief operating officer 78

9.1.17 Jul 17, 2019: Stimwave appoints Regina E. Groves and Marc A. Loev, M.D., to Board of Directors and James M. Rallo as Chief Financial Officer 78

9.1.18 Jul 03, 2019: Neuronetics appoints Stephen Furlong as Chief Financial Officer 79

9.1.19 Jun 25, 2019: Nevro announces executive appointments 79

9.1.20 Jun 10, 2019: electroCore announces Frank R. Amato to step down as chief executive officer 80

9.1.21 May 20, 2019: Nevro appoints D. Keith Grossman Chairman of the Board; Michael DeMane as Lead Director 80

9.1.22 May 20, 2019: Dymedix Diagnostics hires new Vice President of sales and business development 80

9.1.23 Apr 05, 2019: Professor Linda Carpenter joins Nexstim's Scientific Advisory Board 81

9.1.24 Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer 81

9.1.25 Mar 19, 2019: Nevro announces new CEO, board appointments and agreement with Broadfin Capital 82

9.1.26 Mar 04, 2019: California Life Sciences Association (CLSA) adds GlaxoSmithKline and Blade Therapeutics to Board 83

9.1.27 Feb 28, 2019: Zynex names new Vice President of Sales and Marketing 83

9.1.28 Feb 26, 2019: SpineX appoints Scientific Advisory Board to guide development of non-invasive medical devices for neuromodulation of the spine 84

9.1.29 Feb 21, 2019: Nihon Kohden appoints new CEO of North American operations 85

9.1.30 Feb 21, 2019: Stimwave named to fast company’s list of 2019 world’s most innovative companies 86

9.1.31 Feb 15, 2019: Neuronetics announces appointment of Dr. Cheryl R. Blanchard to its Board of Directors 86

9.1.32 Feb 12, 2019: Sanofi names Ameet Nathwani as chief digital officer 87

9.1.33 Feb 06, 2019: Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director 87

9.1.34 Jan 03, 2019: NuVasive CEO J. Christopher Barry announces new organizational structure and Leadership Team 88

9.2 Financial Announcements 89

9.2.1 Nov 27, 2019: Strong half year result for Fisher & Paykel Healthcare: Net Profit up 24% 89

9.2.2 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results 89

9.2.3 Nov 13, 2019: electroCore announces third quarter 2019 financial results 91

9.2.4 Nov 12, 2019: Helius Medical Technologies reports third quarter 2019 financial results and provides business 92

9.2.5 Nov 12, 2019: MRI Interventions reports 62% increase in 2019 third quarter revenue 94

9.2.6 Nov 12, 2019: Dynatronics reports first quarter results for fiscal 2020 95

9.2.7 Nov 07, 2019: Salimetrics releases new Salivary Osteocalcin Test to support interdisciplinary research 96

9.2.8 Nov 07, 2019: Hanger reports third quarter 2019 financial results 98

9.2.9 Nov 06, 2019: Nevro reports third quarter 2019 financial results 100

9.2.10 Nov 05, 2019: Avanos Medical announces third quarter 2019 results, completes acquisition of Endoclear 100

9.2.11 Nov 05, 2019: Neuronetics reports third quarter 2019 financial and operating results 102

9.2.12 Nov 05, 2019: Inspire Medical Systems, announces third quarter 2019 financial results and increases 2019 outlook 103

9.2.13 Oct 30, 2019: NuVasive announces third quarter 2019 financial results 104

9.2.14 Oct 29, 2019: Zynex announces 2019 third quarter financial results 105

9.2.15 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 106

9.2.16 Oct 17, 2019: NeuroMetrix reports Q3 2019 financial results 107

9.2.17 Sep 25, 2019: Dynatronics reports fourth quarter and full year results for fiscal 2019 108

9.2.18 Aug 15, 2019: SANUWAVE Health reports second quarter 2019 financial results 108

9.2.19 Aug 13, 2019: electroCore announces second quarter 2019 financial results 110

9.2.20 Aug 08, 2019: Nevro reports second quarter 2019 financial results 111

9.2.21 Aug 08, 2019: Helius Medical Technologies Reports Second Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook 112

9.2.22 Aug 07, 2019: Hanger reports second quarter 2019 financial results 114

9.2.23 Aug 06, 2019: Avanos Medical announces second quarter 2019 results 116

9.2.24 Aug 06, 2019: Neuronetics reports second quarter 2019 financial and operating results 117

9.2.25 Aug 06, 2019: Inspire Medical Systems announces second quarter 2019 financial results and increases 2019 outlook 118

9.2.26 Aug 06, 2019: MRI Interventions reports 58% increase in 2019 second quarter revenue 119

9.2.27 Aug 01, 2019: Integer Holdings reports second quarter 2019 results 120

9.2.28 Jul 31, 2019: LivaNova reports second quarter 2019 results 120

9.2.29 Jul 31, 2019: Zynex announces 2019 second quarter earnings 121

9.2.30 Jul 30, 2019: NuVasive announces second quarter 2019 financial results 122

9.2.31 Jul 24, 2019: Boston Scientific announces results for second quarter 2019 123

9.2.32 Jul 18, 2019: NeuroMetrix reports Q2 2019 financial results 124

9.2.33 Jun 17, 2019: Dyne Therapeutics announces support for END-DM1 natural history study of patients with Myotonic Dystrophy Type 1 (DM1) 125

9.2.34 May 21, 2019: Sanuwave Health reports first quarter 2019 financial results 126

9.2.35 May 14, 2019: electroCore reports first quarter 2019 financial results 128

9.2.36 May 14, 2019: Dynatronics reports financial results for third fiscal quarter 2019 128

9.2.37 May 09, 2019: Nevro reports first quarter 2019 financial results 129

9.2.38 May 09, 2019: Helius Medical Technologies reports first quarter 2019 financial results and provides business update; reaffirms full year 2019 outlook 130

9.2.39 May 08, 2019: Hanger announces financial results for the first quarter of 2019 131

9.2.40 May 07, 2019: Avanos Medical announces first quarter 2019 results 132

9.2.41 May 07, 2019: Neuronetics announces first quarter 2019 financial results 134

9.2.42 May 07, 2019: Inspire Medical Systems announces first quarter 2019 financial results and increases 2019 outlook 134

9.2.43 May 02, 2019: Integer Holdings reports first quarter 2019 results 135

9.2.44 May 01, 2019: NuVasive announces first quarter 2019 financial results 136

9.2.45 Apr 30, 2019: Zynex Announces 2019 First Quarter Earnings 137

9.2.46 Apr 30, 2019: MRI Interventions Reports 52% Increase in First Quarter Revenue 138

9.2.47 Apr 25, 2019: Neurometrix reports Q1 2019 financial results 139

9.2.48 Apr 24, 2019: Boston Scientific announces results for first quarter 2019 140

9.2.49 Apr 18, 2019: Mainstay Medical provides company update and publishes 2018 full year results 141

9.2.50 Mar 29, 2019: SANUWAVE Health reports record 2018 financial results 142

9.2.51 Mar 29, 2019: SANUWAVE Health reports record 2018 financial results 144

9.2.52 Mar 27, 2019: electroCore announces fourth quarter and full year 2018 financial results 145

9.2.53 Mar 14, 2019: Helius Medical Technologies reports fourth quarter and full year 2018 financial results and introduces full year 2019 outlook 146

9.2.54 Mar 14, 2019: Hanger reports fourth quarter 2018 results and provides 2019 outlook 148

9.2.55 Mar 11, 2019: MRI Interventions reports 36% increase in fourth quarter revenue and record quarterly clearpoint cases 150

9.2.56 Mar 05, 2019: Neuronetics reports fourth quarter and full year 2018 financial and operating results 152

9.2.57 Mar 05, 2019: Neuronetics announces fourth quarter and full year 2018 financial and operating results 153

9.2.58 Feb 27, 2019: LivaNova reports fourth quarter and full-year 2018 results 155

9.2.59 Feb 26, 2019: Avanos Medical announces fourth quarter and full-year 2018 results, provides 2019 outlook 157

9.2.60 Feb 26, 2019: Inspire Medical Systems announces fourth quarter and full year 2018 financial results 159

9.2.61 Feb 21, 2019: Nevro reports fourth quarter and full year 2018 financial results 160

9.2.62 Feb 21, 2019: Integer Holdings reports results for fourth quarter and full year 2018 161

9.2.63 Feb 20, 2019: NuVasive reports fourth quarter and full year 2018 financial results 162

9.2.64 Feb 13, 2019: Dynatronics Announces Financial Results for Second Fiscal Quarter 2019 163

9.2.65 Feb 06, 2019: Boston Scientific announces results for fourth quarter and full year 2018 163

9.2.66 Jan 24, 2019: NeuroMetrix reports Q4 and full year 2018 financial results 165

9.2.67 Jan 14, 2019: Carl Zeiss Meditec achieves strong revenue and EBIT growth in first three months 2018/19 166

9.2.68 Jan 08, 2019: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2018 166

9.2.69 Jan 07, 2019: Neuronetics announces preliminary fourth quarter and full year revenue 166

9.2.70 Jan 07, 2019: NuVasive Announces Preliminary Unaudited Fourth Quarter And Full Year 2018 Revenue Results 167

9.2.71 Jan 07, 2019: Nevro announces preliminary unaudited fourth quarter and full year 2018 revenue 168

9.3 Government and Public Interest 168

9.3.1 Apr 08, 2019: Inspire Medical Systems announces three new positive coverage policies issued by Blue Cross Blue Shield Plans 168

9.3.2 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare 168

9.4 Legal And Regulatory 169

9.4.1 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 169

9.4.2 Oct 30, 2019: SANUWAVE successfully completes extensive round of quality system and technical file audits 170

9.4.3 Aug 27, 2019: Alphatec announces favorable judgment in NuVasive v. Miles lawsuit 170

9.4.4 Jul 16, 2019: Swiss agree to extradite Chinese researcher in US corporate espionage case 171

9.4.5 May 04, 2019: Vectura wins US GSK Patent Litigation and awarded $89.7Million in damages by Trial Jury 172

9.4.6 Feb 21, 2019: Stimwave addresses patent infringement lawsuit brought by Nevro 172

9.4.7 Feb 21, 2019: Fisher & Paykel Healthcare confirms no material impact on earnings guidance 173

9.4.8 Feb 15, 2019: BRAVO BIDCO: Update on the proposed acquisition of BTG 173

9.4.9 Jan 22, 2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences 173

9.4.10 Jan 15, 2019: Boston Scientific, Edwards Lifesciences agree to global litigation settlement 173

9.5 Other Significant Developments 174

9.5.1 Nov 12, 2019: Integer announces commitments to reprice and extend maturity of its revolving credit facility and term Loan A; launches term Loan B repricing 174

9.5.2 Oct 22, 2019: EPFL spin-off GTX medical moves into the US market 174

9.5.3 Oct 08, 2019: University of Pittsburgh: Improving neural implants 174

9.5.4 Oct 07, 2019: UI pain researchers are part of major national effort to curb opioid use 175

9.5.5 Sep 10, 2019: Kazan Federal University and Mayo Clinic implement unique rehabilitation technology to treat spinal cord injuries 176

9.5.6 Aug 28, 2019: Fisher & Paykel Healthcare upgrades Guidance 176

9.5.7 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica 177

9.5.8 Jul 11, 2019: Joe Montana professional Football Hall of Famer joins Stimwave Technologies as official spokesperson 178

9.5.9 Jun 27, 2019: NeuroMetrix provides strategic update 178

9.5.10 May 30, 2019: Nuvasive SpineTRACK Registry successfully meets 2018 medicare reporting requirements for merit-based incentive payments system 179

9.5.11 May 15, 2019: Abbott partners NIH to advance neurostimulation therapies 179

9.5.12 May 06, 2019: Inspire Medical Systems announces additional

11.2 million covered lives with new blue cross blue shield coverage policies 180

9.5.13 Apr 10, 2019: SANUWAVE provides an update on international registrations received, attendance at Trade Shows and ISO Certification 180

9.5.14 Apr 02, 2019: Greenbrook TMS selected by Kaiser Permanente as provider of TMS therapy services in the Mid-Atlantic States 181

9.5.15 Mar 19, 2019: Zynex reactivates medicare provider number in effort to accelerate growth 181

9.5.16 Mar 11, 2019: New genetic data from Regeneron and GSK on 50,000 UK Biobank participants made available to global health research community 182

9.5.17 Mar 04, 2019: Inspire Medical Systems announces five new positive coverage policies issued by Blue Cross Blue Shield Plans 183

9.5.18 Jan 23, 2019: Sanofi joins Startup Creasphere – Munich's first digital health focused innovation program 183

9.5.19 Jan 21, 2019: FocusCura subsidiary Luscii will continue as independent company with partner OMRON Healthcare to accelerate their international expansion 184

9.5.20 Jan 07, 2019: Inspire Medical Systems announces issuance of positive assessment for inspire therapy by Blue Cross Blue Shield Association''s Evidence Street 185

9.6 Product News 185

9.6.1 Nov 26, 2019: Minimally invasive procedure relieves tremors in Parkinson's Patients 185

9.6.2 Aug 16, 2019: RPW Technology announces the launch Of Liftid Neurostimulation 186

9.6.3 Aug 14, 2019: Dynatronics to attend The National by FCA 2019 186

9.6.4 Aug 08, 2019: NuVasive presents long-term strategy and financial outlook at 2019 investor day 187

9.6.5 May 28, 2019: Brain stimulation may improve sight recovery after stroke 187

9.6.6 Apr 24, 2019: Dynatronics to attend the IMCO 2019 National Convention 188

9.6.7 Apr 04, 2019: Dynatronics to attend the NDC Exhibition 2019 188

9.6.8 Mar 07, 2019: Dynatronics to attend the American Academy of Orthopaedic Surgeons 2019 Annual Meeting 188

9.7 Strategy And Business Planning 188

9.7.1 Oct 15, 2019: Subtle Medical receives FDA 510(k) clearance for AI-powered SubtleMR 188

9.7.2 Oct 15, 2019: Sanofi opens digital manufacturing facility in the US 189

9.7.3 Jun 24, 2019: Boston Scientific Galway expands in to new facility 190

9.7.4 May 21, 2019: Verily forms strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to transform clinical research 191

9.7.5 May 09, 2019: Greenbrook TMS announces expansion into Michigan 192

9.7.6 Apr 23, 2019: SANUWAVE Health Enters the Carolinas, Hires Key Representative and Will Participate in the Modern Wound Care Management Conference 192

9.7.7 Mar 12, 2019: Zynex expands corporate headquarters to accommodate growth 193

10 Appendix 194

10.1 Research Methodology 195

10.1.1 Coverage 195

10.1.2 Secondary Research 195

10.1.3 Primary Research 196

10.1.4 Market Modeling and Forecasting 197

10.1.5 Company Share Analysis 198

10.1.6 Distribution Share Analysis 199

10.1.7 Benchmarking 199

10.2 GlobalData Consulting 200

10.3 Contact Us 200

10.4 Disclaimer 200

Table

1.1 List of Tables

Table 1: Neuromodulation Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 11

Table 2: Neuromodulation Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2020 13

Table 3: Neuromodulation Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2021-2025 14

Table 4: Neuromodulation Devices Market, North America, Volume (Units), 2015-2025 16

Table 5: Neuromodulation Devices Market, North America, Volume (Units), 2015-2020 18

Table 6: Neuromodulation Devices Market, North America, Volume (Units), 2021-2025 19

Table 7: Neuromodulation Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2018 21

Table 8: Neuromodulation Devices Market, Canada, Revenue ($m), USD Constant, 2015-2020 23

Table 9: Neuromodulation Devices Market, Canada, Revenue ($m), USD Constant, 2021-2025 24

Table 10: Neuromodulation Devices Market, Canada, Volume (Units), 2015-2020 26

Table 11: Neuromodulation Devices Market, Canada, Volume (Units), 2021-2025 27

Table 12: Neuromodulation Devices Market, Canada, Average Price ($), 2015-2020 28

Table 13: Neuromodulation Devices Market, Canada, Average Price ($), 2021-2025 29

Table 14: Neuromodulation Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2018 30

Table 15: Neuromodulation Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2018 32

Table 16: Neuromodulation Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2020 34

Table 17: Neuromodulation Devices Market, Mexico, Revenue ($m), USD Constant, 2021-2025 35

Table 18: Neuromodulation Devices Market, Mexico, Volume (Units), 2015-2020 37

Table 19: Neuromodulation Devices Market, Mexico, Volume (Units), 2021-2025 38

Table 20: Neuromodulation Devices Market, Mexico, Average Price ($), 2015-2020 39

Table 21: Neuromodulation Devices Market, Mexico, Average Price ($), 2021-2025 40

Table 22: Neuromodulation Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2018 41

Table 23: Neuromodulation Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2018 43

Table 24: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 45

Table 25: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 46

Table 26: Neuromodulation Devices Market, United States, Volume (Units), 2015-2020 48

Table 27: Neuromodulation Devices Market, United States, Volume (Units), 2021-2025 49

Table 28: Neuromodulation Devices Market, United States, Average Price ($), 2015-2020 50

Table 29: Neuromodulation Devices Market, United States, Average Price ($), 2021-2025 51

Table 30: Neuromodulation Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 52

Table 31: Neuromodulation Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2018 54

Table 32: Neuromodulation Devices Market Pipeline Products 57

Table 33: Total Number of Primary Research Participants, Neurology Devices Market, by Country 196

Figures

1.2 List of Figures

Figure 1: Neuromodulation Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2015-2025 11

Figure 2: Neuromodulation Devices Market, North America, Revenue ($m), Historic, USD Constant, 2015-2025 13

Figure 3: Neuromodulation Devices Market, North America, Volume (Units), 2015-2025 16

Figure 4: Neuromodulation Devices Market, North America, Volume (Units), 2015-2025 18

Figure 5: Neuromodulation Devices Market, North America, Company Share (%) 2018 21

Figure 6: Neuromodulation Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025 23

Figure 7: Neuromodulation Devices Market, Canada, Volume (Units), 2015-2025 26

Figure 8: Neuromodulation Devices Market, Canada, Company Share (%) 2018 32

Figure 9: Neuromodulation Devices Market, Mexico, Revenue ($m), USD Constant, 2015-2025 34

Figure 10: Neuromodulation Devices Market, Mexico, Volume (Units), 2015-2025 37

Figure 11: Neuromodulation Devices Market, Mexico, Company Share (%) 2018 43

Figure 12: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 45

Figure 13: Neuromodulation Devices Market, United States, Volume (Units), 2015-2025 48

Figure 14: Neuromodulation Devices Market, United States, Company Share (%) 2018 54

Frequently asked questions

North America Neuromodulation Devices Outlook to 2025 standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Neurology Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Neuromodulation Devices Outlook to 2025 in real time.

  • Access a live North America Neuromodulation Devices Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more